Needle-free injection is an injector which delivers medicine to subcutaneous tissue and intramuscular. The global needle-free injection system market is growing at significant rate, due to mounting occurrence of chronic diseases, and technological improvement. Different types contributed to the needle-free injection system market size. The market has witnessed high demand for liquid-based needle-free injectors due to Benefits of this type have extracted the awareness of various market players.

Download Free Report Sample At: https://www.vynzresearch.com/healthcare/needle-free-injection-system-market/request-sample

Mounting need for biosimilars and vaccination and benefits of drug delivery technology are also driving the growth of the market. According to the World Health Organization (WHO), globally approximately 16 billion injections are administered every year in developing and transitional countries.

The higher price of development and alternative modes of drug delivery are the major challenges for the growth of needle-free injection system market.

Globally, the manufacturing companies trying to enter the needle-free injection system market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest needle-free injection system market as in the region the prevalence of chronic disease is increasing. Mounting need for self-administration, and benefits by needle-free injection systems are also up surging growth of the North American needle-free injection system market. For instance, according to Centers for Disease Control and Prevention in 2012, approximately 117 million people in the U.S. had one or the more chronic conditions.

Europe is observed to witness fastest growth in the market, due to mounting healthcare expenditure and escalating need for biologics. In addition, mounting occurrence of chronic diseases, promising reimbursement plans, technological developments, and regulatory consents of novel injection system are also creating a positive impact on the needle-free injection system market growth in the region.

Read More: https://www.vynzresearch.com/healthcare/needle-free-injection-system-market

Key players in the needle-free injection system market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In February 2018, Antares Pharma, Inc. received FDA approval for Makena subcutaneous auto injector, to reduce the risk of preterm birth in women. Antares Pharma, Inc., European Pharma Group, National Medical Products, Inc., Endo International PLC, Penject Corporation, Injex Pharma AG, Pharmajet, Valeritas, Inc., Medical International Technology, Inc. (MIT), National Medical Products, Inc. and Crossject are the key players offering needle-free injection system.

About VynZ Research
VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

Contact

Manager: Client Care

Toll-Free: 18882533960

Email: [email protected]

Website: www.vynzresearch.com